WO2008045015A8 - Imino and amino sugar purification - Google Patents

Imino and amino sugar purification Download PDF

Info

Publication number
WO2008045015A8
WO2008045015A8 PCT/US2006/022756 US2006022756W WO2008045015A8 WO 2008045015 A8 WO2008045015 A8 WO 2008045015A8 US 2006022756 W US2006022756 W US 2006022756W WO 2008045015 A8 WO2008045015 A8 WO 2008045015A8
Authority
WO
WIPO (PCT)
Prior art keywords
imino
amino sugar
purification
sugar purification
processes
Prior art date
Application number
PCT/US2006/022756
Other languages
French (fr)
Other versions
WO2008045015A1 (en
Inventor
Michael Major
Robert Peterson
Szymon Kosinski
Original Assignee
Amicus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PL06772888T priority Critical patent/PL2027137T3/en
Priority to BRPI0613222-7A priority patent/BRPI0613222A2/en
Priority to ES06772888.1T priority patent/ES2537089T3/en
Priority to EP06772888.1A priority patent/EP2027137B1/en
Priority to SI200631928T priority patent/SI2027137T1/en
Priority to JP2009514248A priority patent/JP5107350B2/en
Application filed by Amicus Therapeutics, Inc. filed Critical Amicus Therapeutics, Inc.
Priority to DK06772888.1T priority patent/DK2027137T3/en
Priority to CN2006800271469A priority patent/CN101277969B/en
Priority to IL187988A priority patent/IL187988A/en
Publication of WO2008045015A1 publication Critical patent/WO2008045015A1/en
Priority to HK09103054.8A priority patent/HK1125111A1/en
Publication of WO2008045015A8 publication Critical patent/WO2008045015A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Abstract

Novel processes for the purification of an imino or amino sugar, such as D-1-deoxygalactonojirimycin (DGJ). Particularly, there are described processes for the purification of multi-kilogram scale sugars using hydrochloric acid.
PCT/US2006/022756 2005-06-08 2006-06-08 Imino and amino sugar purification WO2008045015A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
BRPI0613222-7A BRPI0613222A2 (en) 2005-06-08 2006-06-08 method for purifying a nitrogen-containing raw sugar and method for purifying crude d-1-deoxygalactonojirimycin (dgj)
ES06772888.1T ES2537089T3 (en) 2005-06-08 2006-06-08 Purification of imino- and amino sugars
EP06772888.1A EP2027137B1 (en) 2005-06-08 2006-06-08 Imino and amino sugar purification
SI200631928T SI2027137T1 (en) 2005-06-08 2006-06-08 Imino and amino sugar purification
JP2009514248A JP5107350B2 (en) 2005-06-08 2006-06-08 Purification of imino and amino sugars
PL06772888T PL2027137T3 (en) 2005-06-08 2006-06-08 Imino and amino sugar purification
DK06772888.1T DK2027137T3 (en) 2005-06-08 2006-06-08 Imino and aminosugar PURIFICATION
CN2006800271469A CN101277969B (en) 2005-06-08 2006-06-09 Purification of imido-sugar and amino-sugar
IL187988A IL187988A (en) 2005-06-08 2007-12-06 Method for purification of a crude d-1-deoxygalactonojirimycin or the hcl salt thereof contaminated with an alkali- or alkaline earth metal-containing compound
HK09103054.8A HK1125111A1 (en) 2005-06-08 2009-03-31 Imino and amino sugar purification

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68913005P 2005-06-08 2005-06-08
US60/689,130 2005-06-08

Publications (2)

Publication Number Publication Date
WO2008045015A1 WO2008045015A1 (en) 2008-04-17
WO2008045015A8 true WO2008045015A8 (en) 2009-11-05

Family

ID=41256089

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/022756 WO2008045015A1 (en) 2005-06-08 2006-06-08 Imino and amino sugar purification

Country Status (13)

Country Link
US (1) US7973157B2 (en)
EP (1) EP2027137B1 (en)
JP (1) JP5107350B2 (en)
CN (1) CN101277969B (en)
BR (1) BRPI0613222A2 (en)
DK (1) DK2027137T3 (en)
ES (1) ES2537089T3 (en)
HK (1) HK1125111A1 (en)
IL (1) IL187988A (en)
PL (1) PL2027137T3 (en)
PT (1) PT2027137E (en)
SI (1) SI2027137T1 (en)
WO (1) WO2008045015A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2955520B1 (en) 2006-05-16 2018-10-31 Amicus Therapeutics, Inc. Treatment options for fabry disease
PL3470077T3 (en) 2008-02-12 2021-04-06 Amicus Therapeutics, Inc. Method to predict response to pharmacological chaperone treatment of diseases
CN103626809B (en) * 2013-12-10 2016-01-20 安徽丰原发酵技术工程研究有限公司 A kind of purification process of glucosamine hydrochloride mother liquid
CA2939698A1 (en) 2014-02-17 2015-08-20 Glaxosmithkline Intellectual Property Development Limited Microbiological process
CA3065298A1 (en) 2017-05-30 2018-12-06 Amicus Therapeutics, Inc. Methods of treating fabry patients having renal impairment
IT201700078102A1 (en) * 2017-07-11 2019-01-11 Dipharma Francis Srl SYNTHESIS OF AN AZAZUCCHERO AND ITS INTERMEDIATES
AU2019217868A1 (en) 2018-02-06 2020-10-01 Amicus Therapeutics, Inc. Use of migalastat for treating fabry disease in pregnant patients
CN114423428A (en) 2019-08-07 2022-04-29 阿米库斯治疗学公司 Methods of treating fabry disease in patients with mutations in the GLA gene
US11623916B2 (en) 2020-12-16 2023-04-11 Amicus Therapeutics, Inc. Highly purified batches of pharmaceutical grade migalastat and methods of producing the same
WO2022132992A1 (en) * 2020-12-16 2022-06-23 Amicus Therapeutics, Inc. Highly purified batches of pharmaceutical grade 1-deoxygalactonojirimycin compounds
CN112500441A (en) * 2020-12-20 2021-03-16 上海彩迩文生化科技有限公司 Preparation process of high-purity glycosyl phosphate

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801261A (en) * 1954-05-28 1957-07-30 Du Pont Alkyl esters of substituted thiocyanooctanoic acids
NO154918C (en) * 1977-08-27 1987-01-14 Bayer Ag ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DERIVATIVES OF 3,4,5-TRIHYDROXYPIPERIDINE.
US4634765A (en) * 1984-12-18 1987-01-06 Merrell Dow Pharmaceuticals Inc. Homodisaccharide hypoglycemic agents
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
US5250545A (en) 1988-02-12 1993-10-05 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitor methods
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US4957926A (en) 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5043273A (en) 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
KR910007655A (en) * 1989-10-03 1991-05-30 엠. 피. 잭슨 Therapeutic Nucleosides
DE3936295A1 (en) * 1989-11-01 1991-05-02 Bayer Ag METHOD FOR PRODUCING INTERMEDIATE PRODUCTS AND SYNTHESISING N- (2-HYDROXYETHYL) -2-HYDROXYMETHYL-3,4,5-TRIHYDROXYPIPERIDINE
IT1236902B (en) * 1989-12-20 1993-04-26 COMMAND DEVICE FOR PISTON NEEDLES IN CROCHET MACHINES
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5273981A (en) * 1990-10-18 1993-12-28 Monsanto Company Intramolecular carbamate derivative of 2,3-Di-O-blocked-1,4-dideoxy-4-fluoro-nojirimycins
US5248779A (en) * 1991-06-17 1993-09-28 Monsanto Company Synthesis of nojirimycin derivatives
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
JP2921544B2 (en) * 1993-07-30 1999-07-19 三菱瓦斯化学株式会社 Purification method of monoalkenylbenzenes
WO1995022975A1 (en) * 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
FR2764304B1 (en) 1997-06-06 1999-07-16 Rhone Poulenc Rorer Sa NEW CLASS OF CATIONIC NUCLEIC ACID TRANSFECTANTS
ES2272054T3 (en) * 1998-02-12 2007-04-16 United Therapeutics Corporation USE OF N-SUBSTITUTED-1,5-DIDESOXI-1,5-IMINO-D-GLUCITOL COMPOUNDS TO TREAT INFECTIONS BY HEPATITIS VIRUSES.
ES2302697T3 (en) 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford LONG CHAIN N-ALQUILIC COMPOUNDS AND OXA DERIVATIVES OF THE SAME AND USE AS ANTIVIRAL COMPOSITIONS.
WO2001036435A1 (en) * 1999-11-16 2001-05-25 Industrial Research Limited Glucofuranoses
JP4060079B2 (en) 2000-03-31 2008-03-12 ミシガン ステイト ユニバーシティー Preparation of 1,5-dideoxy-1,5-iminohexitol from oxime or imine
JP2002087808A (en) * 2000-09-14 2002-03-27 Showa Denko Kk Adsorbent for purifying perfluorocarbon, manufacturing method thereof, high purity octafluorocyclobutane, method of purifying and manufacturing the same and utilization thereof
NZ520108A (en) * 2002-07-10 2004-09-24 Ind Res Ltd Process for preparing kifunensine (cyclic oxamide derivative of 1-amino-mannojirimycin) intermediate and kifunensine therefrom

Also Published As

Publication number Publication date
IL187988A0 (en) 2009-02-11
SI2027137T1 (en) 2015-06-30
ES2537089T3 (en) 2015-06-02
EP2027137B1 (en) 2015-02-18
DK2027137T3 (en) 2015-05-18
US20060293515A1 (en) 2006-12-28
EP2027137A1 (en) 2009-02-25
HK1125111A1 (en) 2009-07-31
US7973157B2 (en) 2011-07-05
BRPI0613222A2 (en) 2010-12-28
JP5107350B2 (en) 2012-12-26
EP2027137A4 (en) 2010-04-14
CN101277969A (en) 2008-10-01
PT2027137E (en) 2015-06-09
WO2008045015A1 (en) 2008-04-17
IL187988A (en) 2014-11-30
JP2009539834A (en) 2009-11-19
PL2027137T3 (en) 2015-08-31
CN101277969B (en) 2012-12-19

Similar Documents

Publication Publication Date Title
WO2008045015A8 (en) Imino and amino sugar purification
WO2006069290A3 (en) Enzymes for starch processing
WO2006131928A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
EP2194043A3 (en) Processes and intermediates
EP1881847B8 (en) Injection solution for rna
IL185244A0 (en) 1-sulfonyl-piperidine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
WO2006127899A3 (en) (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
WO2006118862A3 (en) Methods for protecting glass
EP1911743B8 (en) Cyclic amine compound
WO2007039903A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2007127292A3 (en) Tigeycline crystalline forms and processes for preparation thereof
HK1098207A1 (en) Altimeter watch
EG25081A (en) Use of prolines for improving growth and/or yield.
EP1992698A4 (en) METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT
WO2008021342A3 (en) Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone )
AU2006241684A1 (en) Novel lactam compound
CA2585802A1 (en) Industrial process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta.,16.beta.-bismethylene-3-oxo-17.alpha.pregn-4-ene-21-carboxylic acid.gamma.-lactone and key-intermediates for this process
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
PL1951879T3 (en) Plants having an increased content of amino sugars
IL185790A0 (en) Amino acid derivatives
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
WO2007013043A3 (en) Processes for the preparation of 7-amino-3-vinyl cephalosporanic acid
DK1756292T3 (en) PROCEDURE FOR FERMENTING SUGAR CONTAINING OLIGOMERIC SUCCHARIDES
WO2007127309A3 (en) Processes for the synthesis of 3-isobutylglutaric acid

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680027146.9

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 187988

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2009514248

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 9806/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2006772888

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06772888

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

ENP Entry into the national phase

Ref document number: PI0613222

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20071207